methyl {1-[(4-methoxyphenyl)carbonyl]isoquinolin-4-yl} acetate | 1233249-54-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: methyl {1-[(4-methoxyphenyl)carbonyl]isoquinolin-4-yl} acetate
• 英文别名: Methyl 2-[1-(4-methoxybenzoyl)isoquinolin-4-yl]acetate
• CAS: 1233249-54-1
• 化学式: C₂₀H₁₇NO₄
• 分子量: 335.359
• InChiKey: AIGFDTOIOVNEBN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  65.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl {1-[(4-methoxyphenyl)carbonyl]isoquinolin-4-yl} acetate 在 三丁基膦 、 偶氮二甲酰胺 、 水 、 三溴化硼 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 氯仿 为溶剂， 反应 4.0h， 生成 2-[1-[4-[2-(4-chlorophenyl)ethoxy]benzoyl]isoquinolin-4-yl]acetic acid
  参考文献：
  名称：

  Isoquinoline derivatives as potent CRTH2 antagonists: Design, synthesis and SAR

  摘要：

  In this study, we describe the synthesis and structure-activity relationship (SAR) of a series of isoquinoline chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists. TASP0376377 (15-20), one of the most potent compounds, showed a potent binding affinity (IC50 = 19 nM) in addition to the excellent functional antagonist activity (IC50 = 13 nM). Moreover, the efficacy of this compound in a chemotaxis assay (IC50 = 23 nM) was in good agreement with its potency as a CRTH2 antagonist. In addition, 15-20 exhibited greater selectivity in binding to CRTH2 than to the DP1 prostanoid receptor (IC50 > 1 mu M) or the enzymes COX-1 and COX-2 (IC50 > 10 mu M). (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.10.025
• 作为产物：
  描述：

  methyl 1-{[4-(tert-butoxycarbonyl)phenyl]carbonyl}isoquinoline-4-carboxylate 在 甲醇 、 草酰氯 、 水 、 silver(I) acetate 、 sodium hydroxide 、 三甲基硅烷化重氮甲烷 作用下， 以 四氢呋喃 、 氯仿 、 乙腈 为溶剂， 生成 methyl {1-[(4-methoxyphenyl)carbonyl]isoquinolin-4-yl} acetate
  参考文献：
  名称：

  Isoquinoline derivatives as potent CRTH2 receptor antagonists: Synthesis and SAR

  摘要：

  Synthesis and structure-activity relationship of a novel series of isoquinoline CRTH2 receptor antagonists are described. One of the most potent compounds, TASP0376377 (6m), showed not only potent binding affinity (IC50 = 19 nM) but also excellent functional antagonist activity (IC50 = 13 nM). TASP0376377 was tested for its ability of a chemotaxis assay to show the effectiveness (IC50 = 23 nM), which was in good agreement with the CRTH2 antagonist potency. Furthermore, TASP0376377 showed sufficient selectivity for binding to CRTH2 over the DP1 prostanoid receptor (IC50 > 1 mu M) and COX-1 and COX-2 enzymes (IC50 > 10 mu M). (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.03.009

文献信息

• ISOQUINOLINE DERIVATIVE
  申请人：Taisho Pharmaceutical Co., Ltd.

  公开号：EP2377851A1

  公开（公告）日：2011-10-19

  A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.

  由式（I）代表的化合物或其药学上可接受的盐具有抑制 CRTH2 的作用，因此可用于预防或治疗过敏性疾病，如哮喘、特应性皮炎和过敏性鼻炎。
• EP2377851
  申请人：——

  公开号：——

  公开（公告）日：——